These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


93 related items for PubMed ID: 2252338

  • 21. The antidepressant effects of 5-HT uptake inhibitors.
    Aberg-Wistedt A.
    Br J Psychiatry Suppl; 1989 Dec; (8):32-40. PubMed ID: 2692638
    [Abstract] [Full Text] [Related]

  • 22. Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats.
    Haddjeri N, Blier P.
    J Psychiatry Neurosci; 2000 Sep; 25(4):378-88. PubMed ID: 11022403
    [Abstract] [Full Text] [Related]

  • 23. Blood platelets as models for central 5-hydroxytryptaminergic neurons.
    Pletscher A, Laubscher A, Graf M, Saner A.
    Ann Biol Clin (Paris); 1979 Sep; 37(1):35-9. PubMed ID: 443611
    [Abstract] [Full Text] [Related]

  • 24. Pros and cons of 5-HT3 receptor antagonists in neuropsychiatric diseases.
    Rahimian R, Fakhfouri G, Zirak MR.
    Biomed Pharmacother; 2019 Oct; 118():109301. PubMed ID: 31402188
    [No Abstract] [Full Text] [Related]

  • 25. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E, Markwardt F.
    Biomed Biochim Acta; 1984 Oct; 43(2):215-20. PubMed ID: 6732757
    [Abstract] [Full Text] [Related]

  • 26. Correlation of inhibitory activity of tryptamine derivatives on serotonin uptake in thrombocyte with van der Waals volume.
    Gupta SP, Singh P, Bindal MC.
    Arzneimittelforschung; 1981 Oct; 31(12):2053-5. PubMed ID: 7199296
    [Abstract] [Full Text] [Related]

  • 27. [New therapeutic possibilities with drugs affecting serotonin receptors].
    Spigset O.
    Tidsskr Nor Laegeforen; 1992 May 20; 112(13):1700-4. PubMed ID: 1509427
    [Abstract] [Full Text] [Related]

  • 28. A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z.
    Suehiro M, Scheffel U, Dannals RF, Ravert HT, Ricaurte GA, Wagner HN.
    J Nucl Med; 1993 Jan 20; 34(1):120-7. PubMed ID: 8418252
    [Abstract] [Full Text] [Related]

  • 29. Amine uptake inhibitors: criteria of selectivity.
    Maître L, Moser P, Baumann PA, Waldmeier PC.
    Acta Psychiatr Scand Suppl; 1980 Jan 20; 280():97-110. PubMed ID: 6996434
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition of serotonin reuptake.
    Fuller RW, Wong DT.
    Fed Proc; 1977 Jul 20; 36(8):2154-8. PubMed ID: 326579
    [Abstract] [Full Text] [Related]

  • 31. Structure-activity relationships of serotonin neurotoxins: effects on serotonin uptake.
    Horn AS.
    Ann N Y Acad Sci; 1978 Jun 12; 305():128-33. PubMed ID: 280246
    [No Abstract] [Full Text] [Related]

  • 32. Specificity of 5-hydroxytryptamine uptake by snail nervous tissue [proceedings].
    Osborne NN, Schröder HU, Neuhoff V.
    Biochem Soc Trans; 1978 Jun 12; 6(3):632. PubMed ID: 669034
    [No Abstract] [Full Text] [Related]

  • 33. Ligand coupling mechanism of the human serotonin transporter differentiates substrates from inhibitors.
    Gradisch R, Schlögl K, Lazzarin E, Niello M, Maier J, Mayer FP, Alves da Silva L, Skopec SMC, Blakely RD, Sitte HH, Mihovilovic MD, Stockner T.
    Nat Commun; 2024 Jan 10; 15(1):417. PubMed ID: 38195746
    [Abstract] [Full Text] [Related]

  • 34. Chronic Intestinal Pseudo-Obstruction: Is There a Connection with Gut Microbiota?
    Radocchia G, Neroni B, Marazzato M, Capuzzo E, Zuccari S, Pantanella F, Zenzeri L, Evangelisti M, Vassallo F, Parisi P, Di Nardo G, Schippa S.
    Microorganisms; 2021 Dec 10; 9(12):. PubMed ID: 34946150
    [Abstract] [Full Text] [Related]

  • 35. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review.
    Edinoff AN, Akuly HA, Hanna TA, Ochoa CO, Patti SJ, Ghaffar YA, Kaye AD, Viswanath O, Urits I, Boyer AG, Cornett EM, Kaye AM.
    Neurol Int; 2021 Aug 05; 13(3):387-401. PubMed ID: 34449705
    [Abstract] [Full Text] [Related]

  • 36. Effects of Akkermansia muciniphila and Faecalibacterium prausnitzii on serotonin transporter expression in intestinal epithelial cells.
    Yaghoubfar R, Behrouzi A, Fateh A, Nojoumi SA, Vaziri F, Khatami S, Siadat SD.
    J Diabetes Metab Disord; 2021 Jun 05; 20(1):1-5. PubMed ID: 34222056
    [Abstract] [Full Text] [Related]

  • 37. Serotonin Transporter Ala276 Mouse: Novel Model to Assess the Neurochemical and Behavioral Impact of Thr276 Phosphorylation In Vivo.
    Meinke C, Quinlan MA, Paffenroth KC, Harrison FE, Fenollar-Ferrer C, Katamish RM, Stillman I, Ramamoorthy S, Blakely RD.
    Neurochem Res; 2022 Jan 05; 47(1):37-60. PubMed ID: 33830406
    [Abstract] [Full Text] [Related]

  • 38. A microbial metabolite synergizes with endogenous serotonin to trigger C. elegans reproductive behavior.
    Chen YC, Seyedsayamdost MR, Ringstad N.
    Proc Natl Acad Sci U S A; 2020 Dec 01; 117(48):30589-30598. PubMed ID: 33199611
    [Abstract] [Full Text] [Related]

  • 39. Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake.
    Blom T, Meinsma R, Rutgers M, Buitenhuis C, Dekken-Van den Burg M, van Kuilenburg ABP, Tytgat GAM.
    EJNMMI Res; 2020 Jul 08; 10(1):78. PubMed ID: 32642907
    [Abstract] [Full Text] [Related]

  • 40. Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect.
    Ortuño MJ, Robinson ST, Subramanyam P, Paone R, Huang YY, Guo XE, Colecraft HM, Mann JJ, Ducy P.
    Nat Med; 2016 Oct 08; 22(10):1170-1179. PubMed ID: 27595322
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.